Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.

Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial. Eur J Heart Fail. 2014 Jun; 16(6):671-7.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Aminobutyrates
Angiotensin Receptor Antagonists
Biphenyl Compounds
Blood Pressure
Double-Blind Method
Drug Combinations
Female
Glomerular Filtration Rate
Heart Atria
Heart Failure
Humans
Male
Natriuretic Peptide, Brain
Neprilysin
Peptide Fragments
Prospective Studies
Stroke Volume
Tetrazoles
Treatment Outcome
Valine
Valsartan

authors with profiles

Michael R. Zile